CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- 4 Shares withheld for taxes Chief Financial Officer gave up 727 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 3,277 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 27,258 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes INTERIM CEO gave up 3,559 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 11,317 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 5,816 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 15,447 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 41,851 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 38,221 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 40,664 shares (to pay taxes)
- 4 Shares withheld for taxes INTERIM CEO gave up 17,436 shares (to pay taxes)
- 4 Gift Chief Scientific Officer gave 15,000 shares (gift)
- 4 Shares withheld for taxes INTERIM CEO gave up 68,343 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes INTERIM CEO gave up 2,721 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 666,666 shares at $2.25 ($1,499,999)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes INTERIM PRESIDENT AND CEO gave up 2,721 shares (to pay taxes)
Page 3 of 21 · 414 filings